高级检索
当前位置: 首页 > 详情页

Efficacy of traditional chinese medicine in the treatment of rash caused by epidermal growth factor receptor inhibitors: A frequency statistics and meta-analysis

文献详情

资源类型:
WOS体系:

收录情况: ◇ 统计源期刊 ◇ ESCI

单位: [1]Beijing University of Chinese Medicine, China-Japan Friendship Hospital, Beijing, China [2]department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: Epidermal growth factor receptor inhibitors meta-analysis rash Traditional Chinese Medicine

摘要:
Objective: The aim of this study is to evaluate the efficacy of Traditional Chinese Medicine (TCM) in the treatment of rash caused by epidermal growth factor receptor inhibitors (EGFRIs). Materials and Methods: Foreign language database (such as PubMed, Web of Science, Cochrane Library, EMBASE) and Chinese language database (such as China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals [VIP], Wangfang, CBM disc) were searched for all trials of TCM in the treatment of rash caused by EGFRIs until January of 2019. We also looked through the references of relevant studies to supplement additional trials. The SPSS 25.0 was used for statistics of TCM with high frequency, and Review Manager 5.3 was used for meta-analysis. Results: A total of 22 studies were included in the study. We selected TCM whose frequency were >3.0%. They were Lonicera japonica(???), Licorice Roots Northwest Origin(???), Cortex Dictamni(???), Radix Sophorae Flavescentis(??), Schizonepeta(??), Saposhnikovia Divaricate(??). The meta-analysis revealed that the efficacy of TCM in treating EGFRIs-related rash was better than that of Western medicine or none. Conclusions: TCM could significantly relieve rash caused by EGFRIs, which is worth popularizing. Moreover, the mechanism deserves to be further explored.

语种:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 全科医学与补充医学 2 区 医学:研究与实验 2 区 药学
JCR分区:
出版当年[2017]版:
最新[2023]版:
Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Q1 PHARMACOLOGY & PHARMACY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2017版] 出版当年五年平均[2013-2017] 出版前一年[2016版]

第一作者:
第一作者单位: [1]Beijing University of Chinese Medicine, China-Japan Friendship Hospital, Beijing, China
通讯作者:
通讯机构: [2]department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China [*1]Department of Integrative Oncology, China-Japan Friendship Hospital, Yinghua Dongie, Hepingli, Beijing 100029, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)